Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete.
Stahl
S M
SM
Clinical Neuroscience Research Center in San Diego and the Department of Psychiatry at the University of California San Diego, USA.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D003511:Cyclohexanols / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D003866:Depressive Disorder / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride